Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rick Chappell

Showing results (1-10 of 57) with videos related to

Pageof 6
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 20, 2012
Competing risk analyses: how are they different and why should you care?Rick Chappell
Clinical Trials (London, England)|October 16, 2018
Comment on Vickers et alRick Chappell
Statistics in Medicine|December 14, 2006
Continuous Bayesian adaptive randomization based on event times with covariates by Cheung et al., Statistics in Medicine 2006; 25:55-70Rick Chappell, Theodore Karrison
Clinical Trials (London, England)|November 11, 2005
Isotonic designs for phase I cancer clinical trials with multiple risk groupsZhilong Yuan, Rick Chappell
JAMA Oncology|April 29, 2016
Describing Differences in Survival CurvesRick Chappell, Xiaotian Zhu
Biometrics|March 14, 2002
Estimation in the cox proportional hazards model with left-truncated and interval-censored dataWei Pan, Rick Chappell
Statistics in Medicine|September 4, 2007
Three-dose-cohort designs in cancer phase I trialsBo Huang, Rick Chappell
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 28, 2020
How to Do Response-adaptive Randomization (RAR) if You Really MustThevaa Chandereng, Rick Chappell
Journal of Statistical Theory and Practice|May 29, 2026
Estimating Baseline Survival Function in the Proportional Hazards Model Under Monotone HazardsYunhong Wu, Rick Chappell
Biometrics|September 17, 2002
A simple technique to evaluate model sensitivity in the continual reassessment methodYing Kuen Cheung, Rick Chappell
Pageof 6

Showing results (1-10 of 57) with videos related to

Sort By:
Pageof 6
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 20, 2012
Competing risk analyses: how are they different and why should you care?Rick Chappell
Clinical Trials (London, England)|October 16, 2018
Comment on Vickers et alRick Chappell
Statistics in Medicine|December 14, 2006
Continuous Bayesian adaptive randomization based on event times with covariates by Cheung et al., Statistics in Medicine 2006; 25:55-70Rick Chappell, Theodore Karrison
Clinical Trials (London, England)|November 11, 2005
Isotonic designs for phase I cancer clinical trials with multiple risk groupsZhilong Yuan, Rick Chappell
JAMA Oncology|April 29, 2016
Describing Differences in Survival CurvesRick Chappell, Xiaotian Zhu
Biometrics|March 14, 2002
Estimation in the cox proportional hazards model with left-truncated and interval-censored dataWei Pan, Rick Chappell
Statistics in Medicine|September 4, 2007
Three-dose-cohort designs in cancer phase I trialsBo Huang, Rick Chappell
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 28, 2020
How to Do Response-adaptive Randomization (RAR) if You Really MustThevaa Chandereng, Rick Chappell
Journal of Statistical Theory and Practice|May 29, 2026
Estimating Baseline Survival Function in the Proportional Hazards Model Under Monotone HazardsYunhong Wu, Rick Chappell
Biometrics|September 17, 2002
A simple technique to evaluate model sensitivity in the continual reassessment methodYing Kuen Cheung, Rick Chappell
Pageof 6